Type in a keyword and see the report right away. Explore your online world!
If you have already a Newsmeter account:
You can free sign up for Newsmeter:
x
HealthDay News — A device-free, on-demand active acupressure intervention offers clinical benefits for patients with...
HealthDay News — Nail disorders and hair and scalp changes occur frequently among glucagon-like peptide-1...
HealthDay News — Opioid use disorder (OUD)-related hospitalizations involving dexmedetomidine administration rose markedly with the...
Dermatology Advisor spoke with Glynis Ablon, MD, on her approach to optimal evaluations of patients...
HealthDay News — For people with epilepsy of child-bearing potential (PWECP) prescribed hormone contraception susceptible...
The Food and Drug Administration (FDA) has approved Hovilpri ® (pritelivir) for use in immunocompromised...
HealthDay News — The amylin-based analog petrelintide achieves meaningful weight reduction for adults with obesity,...
Par Health has issued a voluntary recall of 22 lots of Argatroban Injection 250mg/2.5mL (100mg/mL)...
New survey findings presented at the 2026 Fall Clinical Dermatology Conference, held October 8 to...
Generalized pustular psoriasis (GPP) is a chronic autoinflammatory skin disease characterized by unpredictable and potentially...
The Food and Drug Administration (FDA) has approved Tecentriq ® (atezolizumab) and Tecentriq Hybreza ®...
MPR Weekly Dose MPR Weekly Dose Podcast #290 — Weltruza, Hovilpri Approved, Atezolizuman Regimens for...
Long-term data support the safety and efficacy of baricitinib in adolescent patients with severe alopecia...
HealthDay News — Statin use is associated with a lower risk for glaucoma incidence and...
Michelle Min, MD, MS, met with the MPR team to discuss multidisciplinary collaboration in the...
